General
Abrilada (Adalimumab)
Virtual visit

Abrilada (Adalimumab)

With our quick and easy online prescription process, you can manage your health effortlessly — whether you need a first-time prescription for Abrilada (Adalimumab) or a refill of an existing one.

Licensed providers in all 50 states

Expert-guided, evidence-based treatments

Skip the trip to the doctor's office

Visit options

Costs shown are for the visit only. You'll pay for medication at your preferred pharmacy.

Video Visit

$25

Est. or $100 w/o insurance

Chat Visit

$30

w/o insurance

Most insurance accepted

Board-certified

No hidden fees

Available nationwide

What is Abrilada (Adalimumab)?

Abrilada is a biosimilar to Humira (adalimumab), a biologic medication that treats a wide range of inflammatory conditions by targeting and neutralizing TNF-alpha—the protein that drives chronic inflammation in diseases like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis. As an FDA-approved biosimilar, Abrilada has been shown to have no clinically meaningful differences from Humira in terms of safety, purity, and potency. It offers the same disease-modifying mechanism at a potentially lower cost. It's given as a subcutaneous injection every one to two weeks.

TNF-alpha neutralization

Binds to and blocks tumor necrosis factor-alpha, interrupting the central inflammatory cytokine responsible for joint destruction, intestinal inflammation, and skin plaques across multiple immune-mediated conditions.

FDA-approved biosimilar equivalence

Abrilada has undergone rigorous regulatory review to confirm it is highly similar to reference adalimumab (Humira) with no clinically meaningful differences in safety or effectiveness—providing the same therapeutic benefit.

Disease-modifying biological therapy

Goes beyond symptom control to interrupt the inflammatory cycle causing progressive structural damage in conditions like rheumatoid arthritis and Crohn's disease—preserving long-term joint and organ function with consistent treatment.

Virtual visit with clinician

Ongoing support, always available.

You’ll be supported by experienced clinicians who care for a wide range of health needs, from everyday concerns to more complex conditions.

Our clinicians track your progress over time and adjust your care as needed. If medication is prescribed, we’ll manage dosing and monitor for side effects. If lab testing is recommended, we review results and refine your plan accordingly. You’re never left to navigate care on your own.

All your care in one place. That’s the General Medicine difference.

We help you understand your options, connect you to the right clinicians, manage prescriptions, coordinate any needed evaluations, and keep an eye on your overall health along the way. It’s comprehensive care that looks at the full picture — your goals, your history, your lifestyle — and makes it simple to move forward with confidence.

Your care plan
Clinician

What our customers have to say

“I feel like I’m finally on the right path to improving my health with the right support now! It’s so refreshing and reassuring.”

Emerald

“My experience with General Medicine was amazing. The understanding and care that was taken to figure out what is exactly going on with me. I feel like a weight has been lifted off of me.”

Kaylee

“I couldn’t be happier with my experience with General Medicine! They are fast, responsive, kind and knowledgeable. It is much easier, more affordable and faster.”

Nika

Get the care you need, without the wait.

Frequently Asked Questions

What is Abrilada and how does it relate to Humira?

Abrilada is an FDA-approved biosimilar to Humira (adalimumab) — confirmed to have no clinically meaningful differences in safety, purity, or potency. It provides the same TNF-alpha blockade for the same range of inflammatory conditions.

Is switching from Humira to Abrilada safe?

FDA biosimilar approval includes an assessment of interchangeability for many biosimilars. Clinicians and insurance plans frequently recommend biosimilars as safe, effective alternatives to the reference product.

How quickly does Abrilada work for rheumatoid arthritis?

Many people notice improvement in joint pain and swelling within 2–4 weeks. For conditions like Crohn's disease or psoriasis, meaningful response may take 4–12 weeks at full therapeutic dosing.

What side effects might I experience?

Injection site reactions, upper respiratory infections, and headache are most common. Because adalimumab suppresses part of the immune system, serious infections including TB reactivation are the most important risks — screened for before starting.

Do I need vaccinations before starting Abrilada?

Yes. Live vaccines cannot be given during adalimumab treatment. Your clinician will review your vaccination history and recommend any needed updates — including flu shot and pneumonia vaccine — before starting.
Logo

© 2026 Path Healthcare Systems Corp.